Cargando…
Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer
Lung cancer continues to be the leading cause for cancer-related deaths in men and women worldwide. Sufficient screening tools enabling early diagnosis are essential to improve patient outcomes. The aim of this study was to evaluate serum midkine (S-MK) both as a diagnostic and prognostic biomarker...
Autores principales: | Stern, Louisa, Mueller, Erik, Bellon, Eugen, Reeh, Matthias, Grotelueschen, Rainer, Guengoer, Cenap, Melling, Nathaniel, Goetz, Mara, Perez, Daniel R., Izbicki, Jakob R., Rawnaq-Möllers, Tamina, Ghadban, Tarik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285415/ https://www.ncbi.nlm.nih.gov/pubmed/34272441 http://dx.doi.org/10.1038/s41598-021-94272-8 |
Ejemplares similares
-
Serum Midkine is a clinical significant biomarker for colorectal cancer and associated with poor survival
por: Kemper, Marius, et al.
Publicado: (2020) -
RAI3 expression is not associated with clinical outcomes of patients with non-small cell lung cancer
por: Melling, Nathaniel, et al.
Publicado: (2023) -
Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade
por: Ghadban, Tarik, et al.
Publicado: (2018) -
Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality
por: Ghadban, Tarik, et al.
Publicado: (2019) -
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients
por: Bellon, Eugen, et al.
Publicado: (2021)